Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
---|
07/11/2002 | US20020090732 Modulator for use in the treatment of brain, psychological and nervous system disorders |
07/11/2002 | US20020090397 Novel suppository form comprising an acid-labile active compound |
07/11/2002 | DE10100938A1 Indol-/Indolin-Hybridfarbstoffe und -hybridfarbstoffvorprodukte Indole / indoline hybrid dyes and -hybridfarbstoffvorprodukte |
07/11/2002 | CA2434124A1 N(phenylsulphonyl)glycine derivatives and their therapeutic use |
07/11/2002 | CA2433779A1 Heterocycle derivatives as ppar-gamma agonists |
07/11/2002 | CA2432959A1 Sodium channel modulators derived from 2-piperidylimidazoles |
07/11/2002 | CA2432184A1 Pharmaceutical compositions of a non-enteric coated proton pump inhibitor with a carbonate salt and bicarbonate salt combination |
07/11/2002 | CA2431679A1 Method for the regioselective preparation of substituted benzo[g]quinoline-3-carbonitriles and benzo[g]quinazolines |
07/11/2002 | CA2431545A1 Excitatory amino acid receptor antagonists |
07/10/2002 | EP1221443A1 Substituted imidazolidinone derivatives |
07/10/2002 | EP1221441A2 LTA4 Hydrolase inhibitors |
07/10/2002 | EP1221440A1 Benzoheterocyclic derivatives useful as vasopressin or oxytocin modulators |
07/10/2002 | EP1221314A1 New crystalline form of omeprazole |
07/10/2002 | EP1220856A2 Pyrazolo[4,3-d]pyrimidine derivatives |
07/10/2002 | EP1220852A1 Substituted diazepans |
07/10/2002 | EP1220845A1 Aryl-sulfonamide substituted benzimidazol derivatives and use of said as tryptase inhibitors |
07/10/2002 | EP1220844A1 Aryl sulfonamide-substituted benzimidazol derivatives thereof as tryptase inhibitors |
07/10/2002 | EP1220842A1 Cyclic amine compounds as ccr5 antagonists |
07/10/2002 | EP1220838A2 1-aziridino-1-hydroxyiminomethyl-derivatives, method for the production thereof and medicaments containing said compounds |
07/10/2002 | EP1220836A2 Benzylcycloalkyl amines as modulators of chemokine receptor activity |
07/10/2002 | EP0819128B1 Tricyclic compounds useful in the treatment of cell proliferative disorders |
07/10/2002 | EP0779277B1 1,4-dihydropyridine derivative |
07/10/2002 | CN1358185A Optically active quinoline carboxylic acid derivatives having T-pyrrolidine substues causing optical activity and process for preparing thereof |
07/10/2002 | CN1358183A Quinolinecarboxylic acid derivative or salts thereof |
07/10/2002 | CN1358182A 呼吸道合胞病毒复制抑制剂 Respiratory syncytial virus replication inhibitors |
07/10/2002 | CN1358181A 呼吸道合胞病毒复制抑制剂 Respiratory syncytial virus replication inhibitors |
07/10/2002 | CN1358180A Respiratory syncytial virus replication inhibitors |
07/10/2002 | CN1358178A Pharmaceutical compounds |
07/10/2002 | CN1358175A Pyrimidinone compounds |
07/10/2002 | CN1087294C Novel compounds |
07/09/2002 | US6417370 Arylphenyl-substituted cyclic keto-enols |
07/09/2002 | US6417366 Chemical intermediate for macrolactone antibiotic |
07/09/2002 | US6417360 Heterocyclic sulfonamides |
07/09/2002 | US6417219 Enzyme inhibitors and osteoarthritis |
07/09/2002 | US6417214 Compounds as contraceptives |
07/09/2002 | US6417209 Heterocyclic ketone and thioester compounds and uses |
07/09/2002 | US6417205 Nicotine in therapeutic angiogenesis and vasculogenesis |
07/09/2002 | US6417204 Cardiovascular disoders |
07/09/2002 | US6417203 Antithrombotic agents |
07/09/2002 | US6417202 3-acetyl-4-methyl-2,5-di(4-pyridyl)-1h-pyrrole, for example; treating cell adhesion molecules (cams) mediated diseases such as arthritis, aids, septic shock, cachexia, transplant rejection |
07/09/2002 | US6417200 Antithrombotic agents |
07/09/2002 | US6417197 Prodrugs formed with esterification and acidification |
07/09/2002 | US6417195 Isoquinoline derivatives and isoquinoline combinatorial libraries |
07/09/2002 | US6417194 Quinolines and quinazolines useful in therapy |
07/09/2002 | US6417192 Pyrimidinone compounds and pharmaceutical compositions containing them |
07/09/2002 | US6417189 Drugs with pyrazole ketone derivatives |
07/09/2002 | US6417185 Heterocyclic enzyme inhibitors |
07/09/2002 | US6417162 Female impotence treated with heterocyclic compound containing nitro groups |
07/09/2002 | US6416733 Radiopharmaceuticals for imaging infection and inflammation |
07/09/2002 | CA2211444C New benzimidazol, benzoxazol and benzothiazol derivitives, the procedure for preparing them and the pharmaceutical compositions which contain them. |
07/04/2002 | WO2002051838A1 Novel benzazepines and related heterocyclic derivatives which are useful as orexin receptor antagonists |
07/04/2002 | WO2002051837A2 Heterocyclindazole and azaindazole compounds as 5-hydroxytryptamine-6 ligands |
07/04/2002 | WO2002051836A1 Dipeptidyl peptidase iv inhibitor |
07/04/2002 | WO2002051835A1 Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives |
07/04/2002 | WO2002051834A1 Farnesyl transferase inhibiting 4-heterocyclyl-quinoline and quinazoline derivatives |
07/04/2002 | WO2002051833A1 3-indoline derivatives useful in the treatment of psychiatric and neurologic disorders |
07/04/2002 | WO2002051832A2 Heterocyclylalkylindole or -azaindole compounds as 5-hydroxytryptamine-6 ligands |
07/04/2002 | WO2002051831A1 Oxybenzamides derivatives as factor xa inhibitors |
07/04/2002 | WO2002051810A2 Integrin receptor ligands |
07/04/2002 | WO2002051809A1 Piperidine mch antagonists and their use in the treatment of obesity |
07/04/2002 | WO2002051808A2 Muscarinic antagonists |
07/04/2002 | WO2002051807A1 Compounds |
07/04/2002 | WO2002051806A1 Carbazole derivatives and their use as neuropeptide y5 receptor ligands |
07/04/2002 | WO2002051397A1 Aniline derivatives or salts thereof and cytokine production inhibitors containing the same |
07/04/2002 | WO2002051232A2 Novel benzazepines and related heterocyclic derivatives |
07/04/2002 | WO2002038543A3 3-substituted oxindole beta 3 agonists |
07/04/2002 | WO2002022576A3 3-substituted indole carbohydrazides useful as cell proliferation and angiogenesis inhibitors |
07/04/2002 | WO2002003991A3 Use of substituted indole compounds for increasing nitric oxide synthase activity |
07/04/2002 | WO2001098275A3 1-aryl-4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents |
07/04/2002 | WO2001064652A9 Substituted 5-methyldihydropyridazinones and their use in the prophylaxis and/or treatment of anemias |
07/04/2002 | WO2000076510A9 Dermal anesthetic agents |
07/04/2002 | US20020087002 Naphthalenyl piperidines as renin inhibitors |
07/04/2002 | US20020086999 Certain quinoline derivatives |
07/04/2002 | US20020086996 N-cyanomethyl amides which are cysteine protease inhibitors; treating osteoporosis; mixtures with bisphosphonates |
07/04/2002 | US20020086882 Regulates immune and inflammatory responses by binding to alpha 4 integrin, also know as Very Late Antigen; antiinflammatory agent |
07/04/2002 | US20020086879 Bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives |
07/04/2002 | US20020086874 Substituted indoline derivative compounds which are antagonists of the progesterone receptor; contraceptives; antineoplastic agents |
07/04/2002 | US20020086872 Anticoagulants; may be embedded in or physically linked to materials used in manufacture of devices used in blood collection, circulation, stents |
07/04/2002 | US20020086869 Treatment of inflammation, arthritis, bone disorders, respiratory system disorders |
07/04/2002 | US20020086863 New arylglycinamide derivatives, processes for the manufacture thereof and pharmaceutical compositions containing these compounds |
07/04/2002 | US20020086862 1,2,4-triazole-3-thione compounds; treatment of disorders such as ischaemia, psoriasis |
07/04/2002 | US20020086859 Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists |
07/04/2002 | US20020086858 Neuropeptide Y antagonists; treatment of eating disorders such as obesity and hyperphagia |
07/04/2002 | CA2433090A1 Dipeptidyl peptidase iv inhibitor |
07/04/2002 | CA2432661A1 Heterocyclylalkylindole or -azaindole compounds as 5-hydroxytryptamine-6 ligands |
07/04/2002 | CA2432654A1 Heterocyclindazole and azaindazole compounds as 5-hydroxytryptamine-6 ligands |
07/04/2002 | CA2432473A1 3-indoline derivatives useful in the treatment of psychiatric and neurologic disorders |
07/04/2002 | CA2432008A1 Carbazole derivatives and their use as neuropeptide y5 receptor ligands |
07/04/2002 | CA2431953A1 Piperidine mch antagonists and their use in the treatment of obesity |
07/03/2002 | EP1219618A1 Quinolinecarboxylic acid derivative or its salt |
07/03/2002 | EP1219609A1 Aromatic nitrogenous six-membered ring compounds |
07/03/2002 | EP1219607A1 Integrase inhibitors containing aromatic heterocycle derivatives |
07/03/2002 | EP1219294A1 Melanin concentrating hormone antagonists |
07/03/2002 | EP1219173A1 Insecticidal and acaricidal agents |
07/03/2002 | EP1218449A2 Monoazo dyestuffs useful for colour filters and ink jet printing |
07/03/2002 | EP1218377A1 AMINO LACTAM SULFONAMIDES AS INHIBITORS OF A$g(b) PROTEIN PRODUCTION |
07/03/2002 | EP1218373A2 2-pyrazolin-5-ones as tyrosine kinase inhibitors |
07/03/2002 | EP1218372A1 Novel spiroheterocyclic compounds useful as reversible inhibitors of cysteine proteases |
07/03/2002 | EP1218371A2 Di-substituted iminoheterocyclic compounds |
07/03/2002 | EP1218370A2 Quinolyl propyl piperidine derivatives and their use as antibacterial agents |